Filing Details

Accession Number:
0001708138-21-000096
Form Type:
4
Zero Holdings:
No
Publication Time:
2021-12-10 17:37:57
Reporting Period:
2021-12-08
Accepted Time:
2021-12-10 17:37:57
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
872589 Regeneron Pharmaceuticals Inc. REGN Pharmaceutical Preparations (2834) 133444607
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1585160 E Robert Landry 777 Old Saw Mill River Road
Tarrytown NY 10591
Evp Finance Cfo No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2021-12-08 3,971 $0.00 29,957 No 4 A Direct
Common Stock Acquisiton 2021-12-09 4,250 $399.66 34,207 No 4 M Direct
Common Stock Disposition 2021-12-09 3,469 $657.11 30,738 No 4 F Direct
Common Stock Disposition 2021-12-10 2 $656.46 30,736 No 4 S Direct
Common Stock Disposition 2021-12-10 50 $657.53 30,686 No 4 S Direct
Common Stock Disposition 2021-12-10 11 $658.52 30,675 No 4 S Direct
Common Stock Disposition 2021-12-10 4 $659.49 30,671 No 4 S Direct
Common Stock Disposition 2021-12-10 25 $661.48 30,646 No 4 S Direct
Common Stock Disposition 2021-12-10 123 $662.06 30,523 No 4 S Direct
Common Stock Disposition 2021-12-10 19 $663.41 30,504 No 4 S Direct
Common Stock Disposition 2021-12-10 15 $664.71 30,489 No 4 S Direct
Common Stock Disposition 2021-12-10 18 $665.44 30,471 No 4 S Direct
Common Stock Disposition 2021-12-10 68 $666.19 30,403 No 4 S Direct
Common Stock Disposition 2021-12-10 7 $667.80 30,396 No 4 S Direct
Common Stock Disposition 2021-12-10 178 $668.21 30,218 No 4 S Direct
Common Stock Disposition 2021-12-10 130 $669.48 30,088 No 4 S Direct
Common Stock Disposition 2021-12-10 58 $670.13 30,030 No 4 S Direct
Common Stock Disposition 2021-12-10 14 $671.42 30,016 No 4 S Direct
Common Stock Disposition 2021-12-10 59 $672.30 29,957 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 A Direct
No 4 M Direct
No 4 F Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Non-Qualified Stock Option (right to buy) Disposition 2021-12-09 4,250 $0.00 4,250 $399.66
Common Stock Non-Qualified Stock Option (right to buy) Acquisiton 2021-12-08 16,958 $0.00 16,958 $644.54
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
17,000 2024-12-16 No 4 M Direct
16,958 2031-12-08 No 4 A Direct
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 229 Indirect By 401(k) Plan
Footnotes
  1. Award of Restricted Stock under the Second Amended and Restated 2014 Long-Term Incentive Plan that vests 50% on December 8, 2023 and 50% on December 8, 2025.
  2. Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c).
  3. Represents volume-weighted average price of sales of 50 shares of Company stock on December 10, 2021 at prices ranging from $657.19 to $657.76. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on December 10, 2021 at each separate price.
  4. Represents volume-weighted average price of sales of 11 shares of Company stock on December 10, 2021 at prices ranging from $658.10 to $658.89. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on December 10, 2021 at each separate price.
  5. Represents volume-weighted average price of sales of 4 shares of Company stock on December 10, 2021 at prices ranging from $659.36 to $659.61. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on December 10, 2021 at each separate price.
  6. Represents volume-weighted average price of sales of 25 shares of Company stock on December 10, 2021 at prices ranging from $661.26 to $661.94. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on December 10, 2021 at each separate price.
  7. Represents volume-weighted average price of sales of 123 shares of Company stock on December 10, 2021 at prices ranging from $662.06 to $662.17. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on December 10, 2021 at each separate price.
  8. Represents volume-weighted average price of sales of 19 shares of Company stock on December 10, 2021 at prices ranging from $663.16 to $663.53. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on December 10, 2021 at each separate price.
  9. Represents volume-weighted average price of sales of 18 shares of Company stock on December 10, 2021 at prices ranging from $665.20 to $665.61. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on December 10, 2021 at each separate price.
  10. Represents volume-weighted average price of sales of 7 shares of Company stock on December 10, 2021 at prices ranging from $667.39 to $667.96. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on December 10, 2021 at each separate price.
  11. Represents volume-weighted average price of sales of 178 shares of Company stock on December 10, 2021 at prices ranging from $668.10 to $668.50. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on December 10, 2021 at each separate price.
  12. Represents volume-weighted average price of sales of 130 shares of Company stock on December 10, 2021 at prices ranging from $669.43 to $669.75. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on December 10, 2021 at each separate price.
  13. Represents volume-weighted average price of sales of 58 shares of Company stock on December 10, 2021 at prices ranging from $670.12 to $670.62. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on December 10, 2021 at each separate price.
  14. Represents volume-weighted average price of sales of 14 shares of Company stock on December 10, 2021 at prices ranging from $671.42 to $671.43. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on December 10, 2021 at each separate price.
  15. The stock option award vests in four equal annual installments, commencing one year after the date of grant.